Fundamentals

Select the financial statements you wish to view below.  The reports below may be viewed on either an annual or quarterly basis.
Data will appear here once earnings are reported.

OTCQXZCOR
All numbers in thousands USD
Period Ending
Dec 31, 2019
Sep 30, 2019
Jun 30, 2019
Mar 31, 2019
Total Revenue
--
22,386
22,034
--
Cost of Revenue
--
10,394
14,172
--
Gross Profit
--
11,992
7,862
--
Operating Expenses
Research Development
--
3
4
--
Selling General and Administrative
--
15,360
16,552
--
Non Recurring
--
--
--
--
Others
--
3,497
3,497
--
Total Operating Expenses
--
18,860
20,053
--
Operating Income or Loss
--
(6,868)
(12,191)
--
Income from Continuing Operations
Total Other Income/Expenses Net
--
327
(3,816)
--
Earnings Before Interest And Taxes
--
(6,868)
(12,191)
--
Interest Expense
--
--
--
--
Income Before Tax
--
(10,290)
(19,643)
--
Income Tax Expense
--
--
0
--
Minority Interest
--
--
--
--
Net Income From Continuing Ops
--
(10,290)
(19,643)
--
Non-recurring Events
Discontinued Operations
--
--
--
--
Extraordinary Items
--
--
--
--
Effect Of Accounting Changes
--
--
--
--
Other Items
--
0
0
--
Net Income
--
(10,290)
(19,643)
--
Preferred Stock And Other Adjustments
--
--
--
--
Net Income Applicable To Common Shares
--
(10,290)
(19,643)
--

 

 

CAREERS

Find out more about opportunities with Zyla Life Sciences.

Career Contact
careers@zyla.com

QUICK LINKS

Sign up for Zyla Life Sciences email alerts.

Investor Contact
ir@zyla.com
Media Contact
media@zyla.com

ZYLA LIFE SCIENCES

U.S. Operations
600 Lee Road, Suite 100
Wayne, PA 19087
Tel: 610.833.4200

© Copyright 2020 Zyla Life Sciences
All rights reserved.